Licochalcone A:: A lipase inhibitor from the roots of Glycyrrhiza uralensis

被引:84
作者
Won, Se-Ra
Kim, Seung-Kyum
Kim, Yong-Mu
Lee, Phil-Ho
Ryu, Jae-Hyung
Kim, Jang-Won
Rhee, Hae-Ik [1 ]
机构
[1] Kangwon Natl Univ, Dept Biotechnol, Chunchon 200701, South Korea
[2] Busan Reg Food & Drug Adm, KFDA, Pusan 608829, South Korea
[3] Kangwon Natl Univ, Dept Chem, Chunchon 200701, South Korea
[4] Kangwon Natl Univ, Inst Biosci & Biotechnol, Chunchon 200701, South Korea
关键词
licochalcone A; lipase inhibitor; Glycyrrhiza uralensis; obesity;
D O I
10.1016/j.foodres.2007.05.005
中图分类号
TS2 [食品工业];
学科分类号
0832 [食品科学与工程];
摘要
In order to develop a functional food and anti-obesity drug through the inhibition of absorption of dietary lipids, we investigated the inhibitory effects on pancreatic lipase of extracts from more than 800 species of herbs in Korea. In this study, licochalcone A was isolated from the ethyl acetate/n-hexane fraction of ethyl acetate extract of the roots of Glycyrrhiza uralensis. Its structure was elucidated by H-1 NMR, C-13 NMR and HR-EI mass spectroscopy. Licochalcone A substantially inhibited activity with IC50 value of 35 mu g/mL (103.4 M). In an investigation of reversibility, licochalcone A was shown to be reversible to pancreatic lipase. The inhibition mode of licochalcone A was a non-competitive inhibitor, determined by Lineweaver-Burk plot analysis, and K-i value was 11.2 mu g/mL (32.8 mu M). Furthermore, licochalcone A significantly reduced the production of oleic acid with not only artificial substrate DNPB but natural substrate triolein by pancreatic lipase. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1046 / 1050
页数:5
相关论文
共 28 条
[1]
Orlistat: its current status as an anti-obesity drug [J].
Ballinger, A ;
Peikin, SR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 440 (2-3) :109-117
[2]
Bray GA, 1999, AM J CLIN NUTR, V70, P572
[3]
Dietary fat intake does affect obesity! [J].
Bray, GA ;
Popkin, BM .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 68 (06) :1157-1173
[4]
The underlying basis for obesity: Relationship to cancer [J].
Bray, GA .
JOURNAL OF NUTRITION, 2002, 132 (11) :3451S-3455S
[5]
LICOCHALCONE A, A NOVEL ANTIPARASITIC AGENT WITH POTENT ACTIVITY AGAINST HUMAN PATHOGENIC PROTOZOAN SPECIES OF LEISHMANIA [J].
CHEN, M ;
CHRISTENSEN, SB ;
BLOM, J ;
LEMMICH, E ;
NADELMANN, L ;
FICH, K ;
THEANDER, TG ;
KHARAZMI, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (12) :2550-2556
[6]
DRENT ML, 1995, INT J OBESITY, V19, P221
[7]
Structure and function of gastro-intestinal lipases [J].
Embleton, JK ;
Pouton, CW .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 25 (01) :15-32
[8]
Prevalence and trends in obesity among US adults, 1999-2000 [J].
Flegal, KM ;
Carroll, MD ;
Ogden, CL ;
Johnson, CL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (14) :1723-1727
[9]
In vitro antimycobacterial and antilegionella activity of licochalcone A from Chinese licorice roots [J].
Friis-Moller, A ;
Chen, M ;
Fuursted, K ;
Christensen, SB ;
Kharazmi, A .
PLANTA MEDICA, 2002, 68 (05) :416-419
[10]
GARGOURI Y, 1984, J LIPID RES, V25, P1214